Johnson & Johnson Finally Receives Data from SGLT-2 Inhibitor, Invokana
Hold onto your hats, pharmaceutical investors! Johnson & Johnson (), an American multinational pharmaceutical company, has finally received it’s data from Invokana, which is a popular SGLT-2 inhibitor used to treat type 2 diabetes.
… Read
Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval
Investors in Adamis Pharmaceuticals Corp. (NASDAQ:$ADMP) were probably celebrating yesterday as the company’s shares flew through the roof by a whopping 53%, hitting a one-year high. The rise was largely due to Adamis’ announcement that …
Mutual Fund Schemes Invested in Pharma Companies Outperform Large Markets
There are numerous mutual funds categories and each allows prospective investors to choose a scheme based on a variety of factors, including the amount of risk that they want to take and the investment term. …
Epizyme Stock Rises with Positive Media Coverage, According to Analysis
Media coverage of biopharmaceutical company Epizyme (NASDAQ:$EPZM) has been pretty positive recently, according to research group Alpha One Sentiment Analysis. Alpha One helps company identify positive and/or negative media coverage through the analysis of more …
Lupin Limited Gets Final Go Ahead for its Oxycodone Hydrochloride Tablets
Lupin Limited (NSE: LUPIN), a major pharmaceutical company, has acquired the final approval from the United States FDA for its Oxycodone Hydrochloride tablets. These tablets will be used to treat patients suffering from severe pain. …
Dr Reddy’s Calls for a Recall of $5,030 USD of Zenatane Tablets from US market
Are you thinking about investing in pharmaceutical companies? If so, let’s take a look at what’s been happening in this sector of the market as of late.
Dr Reddy’s Laboratories (NYSE:$RDY), an Indian …
5 Surprising Things About Eli Lilly and Co.
Many things have been changing within one of the world’s largest pharmaceutical companies, Eli Lilly and Company (NYSE:$LLY) lately, causing the company’s shares to be a bit unstable. Besides beginning 2017 with a new CEO, …
Three Reasons Why Some Investors Think Johnson & Johnson is a Bearish Stock
With long-time running pharmaceutical company Johnson & Johnson (NYSE:$JNJ) seeing some promising rises in its shares, many investors have quite a bullish view on the company’s stock.
However, some investors still have a …
Oasmia Pharmaceutical’s Stock Increases After Company Signs Deal with Hetero Group
If you’re looking for the best pharmaceutical companies to invest in, you should know that Oasmia Pharmaceutical AB (STO:$OASM), a Swedish company that focuses on the development of drugs within the fields of human and …
RedHill Biopharma Ltd – ADR Stock Rises After Positive Phase III Results of BEKINDA Treatment
Israel-based biopharmaceutical company RedHill Biopharma Ltd – ADR (NASDAQ:$RDHL) saw its stocks rise after the company’s release of the results from its Phase III clinical trial named GUARD. GUARD tested the performance of using RHB-102 …